Clarify2020 - Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment

It will collect data about survivors from breast, lung and lymphoma cancer (the most prevalent types) from hospitals in Spain.

Using big data and artificial intelligence techniques, it will integrate all data with relevant publicly available biomedical information, as well as information from wearable devices used after the treatment.

The data will be analysed to predict patient-specific risk of developing secondary effects and toxicities from their cancer treatments.